786 related articles for article (PubMed ID: 15003036)
1. Benefit-risk assessment of long-acting beta2-agonists in asthma.
Jackson CM; Lipworth B
Drug Saf; 2004; 27(4):243-70. PubMed ID: 15003036
[TBL] [Abstract][Full Text] [Related]
2. Antagonism of long-acting beta2-adrenoceptor agonism.
Lipworth BJ
Br J Clin Pharmacol; 2002 Sep; 54(3):231-45. PubMed ID: 12236842
[TBL] [Abstract][Full Text] [Related]
3. A benefit-risk assessment of inhaled long-acting beta2-agonists in the management of obstructive pulmonary disease.
Sovani MP; Whale CI; Tattersfield AE
Drug Saf; 2004; 27(10):689-715. PubMed ID: 15350154
[TBL] [Abstract][Full Text] [Related]
4. Scientific rationale for inhaled combination therapy with long-acting beta2-agonists and corticosteroids.
Barnes PJ
Eur Respir J; 2002 Jan; 19(1):182-91. PubMed ID: 11843317
[TBL] [Abstract][Full Text] [Related]
5. Combination therapy of long-acting beta2-adrenoceptor agonists and corticosteroids for asthma.
Chung KF; Adcock IM
Treat Respir Med; 2004; 3(5):279-89. PubMed ID: 15606218
[TBL] [Abstract][Full Text] [Related]
6. Association of Inhaled Corticosteroids and Long-Acting β-Agonists as Controller and Quick Relief Therapy With Exacerbations and Symptom Control in Persistent Asthma: A Systematic Review and Meta-analysis.
Sobieraj DM; Weeda ER; Nguyen E; Coleman CI; White CM; Lazarus SC; Blake KV; Lang JE; Baker WL
JAMA; 2018 Apr; 319(14):1485-1496. PubMed ID: 29554195
[TBL] [Abstract][Full Text] [Related]
7. Inhaled corticosteroids as combination therapy with beta-adrenergic agonists in airways disease: present and future.
Chung KF; Caramori G; Adcock IM
Eur J Clin Pharmacol; 2009 Sep; 65(9):853-71. PubMed ID: 19557399
[TBL] [Abstract][Full Text] [Related]
8. Treatment of persistent asthma with Symbicort (budesonide/formoterol inhalation aerosol): an inhaled corticosteroid and long-acting beta2-adrenergic agonist in one pressurized metered-dose inhaler.
Berger WE; Noonan MJ
J Asthma; 2010 May; 47(4):447-59. PubMed ID: 20528601
[TBL] [Abstract][Full Text] [Related]
9. Long-acting beta2-adrenoceptor agonists: a smart choice for asthma?
Lipworth BJ
Trends Pharmacol Sci; 2007 Jun; 28(6):257-62. PubMed ID: 17466387
[TBL] [Abstract][Full Text] [Related]
10. Long-acting beta2-agonists or leukotriene receptor antagonists as add-on therapy to inhaled corticosteroids for the treatment of persistent asthma.
Ringdal N
Drugs; 2003; 63 Suppl 2():21-33. PubMed ID: 14984078
[TBL] [Abstract][Full Text] [Related]
11. Nocturnal asthma uncontrolled by inhaled corticosteroids: theophylline or long-acting beta2 agonists?
Holimon TD; Chafin CC; Self TH
Drugs; 2001; 61(3):391-418. PubMed ID: 11293649
[TBL] [Abstract][Full Text] [Related]
12. Combination therapy of inhaled corticosteroids and long-acting beta2-adrenergics in management of patients with chronic obstructive pulmonary disease.
Sin DD; Johnson M; Gan WQ; Man SF
Curr Pharm Des; 2004; 10(28):3547-60. PubMed ID: 15579052
[TBL] [Abstract][Full Text] [Related]
13. Corticosteroids and adrenoceptor agonists: the compliments for combination therapy in chronic airways diseases.
Sin DD; Man SF
Eur J Pharmacol; 2006 Mar; 533(1-3):28-35. PubMed ID: 16457807
[TBL] [Abstract][Full Text] [Related]
14. Long-acting beta2-agonists in asthma: not so SMART?
Currie GP; Lee DK; Lipworth BJ
Drug Saf; 2006; 29(8):647-56. PubMed ID: 16872239
[TBL] [Abstract][Full Text] [Related]
15. Advances in asthma and COPD treatment: combination therapy with inhaled corticosteroids and long-acting beta 2-agonists.
Miller-Larsson A; Selroos O
Curr Pharm Des; 2006; 12(25):3261-79. PubMed ID: 17020533
[TBL] [Abstract][Full Text] [Related]
16. The impact of inhaled corticosteroid and long-acting beta-agonist combination therapy on outcomes in COPD.
Hanania NA
Pulm Pharmacol Ther; 2008; 21(3):540-50. PubMed ID: 18280761
[TBL] [Abstract][Full Text] [Related]
17. Airway subsensitivity with long-acting beta 2-agonists. Is there cause for concern?
Lipworth BJ
Drug Saf; 1997 May; 16(5):295-308. PubMed ID: 9187530
[TBL] [Abstract][Full Text] [Related]
18. Long-acting beta 2-adrenoceptor agonists and exercise-induced asthma: lessons to guide us in the future.
Anderson SD; Brannan JD
Paediatr Drugs; 2004; 6(3):161-75. PubMed ID: 15170363
[TBL] [Abstract][Full Text] [Related]
19. What is new with the beta2-agonists: issues in the management of asthma.
Kelly HW
Ann Pharmacother; 2005 May; 39(5):931-8. PubMed ID: 15811904
[TBL] [Abstract][Full Text] [Related]
20. Inhaled corticosteroid and long-acting β2-agonist pharmacological profiles: effective asthma therapy in practice.
Tamm M; Richards DH; Beghé B; Fabbri L
Respir Med; 2012 Dec; 106 Suppl 1():S9-19. PubMed ID: 23273165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]